BIOTON S.A. (FRA:7U5)

Market Cap	79.71M
Revenue (ttm)	69.32M
Net Income (ttm)	-661.58K
Shares Out	n/a
EPS (ttm)	-0.01
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	n/a
Open	0.9260
Previous Close	0.9300
Day's Range	0.9260 - 0.9260
52-Week Range	0.6390 - 1.1500
Beta	n/a
RSI	44.73
Earnings Date	Feb 6, 2026

About BIOTON

BIOTON S.A., a biotechnology company, develops, manufactures, markets, and sells pharmaceutical ingredient and medicinal products in Poland and internationally. The company offers recombinant human insulin; oral diabetic drugs; strips for measuring sugar in blood, as well as Gensulin N, Gensulin R, and Gensulin M30; GensuPen 2, an automatic injection system; and GensuCare glucometer, a diabetes monitoring technology, as well as needles. BIOTON S.A. was founded in 1989 and is based in Ozarów Mazowiecki, Poland.

• Industry: Pharmaceutical Preparations
• Founded: 1989
• Employees: 364
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 7U5

Financial Performance

Financial numbers in PLN